Evaluating the Shift to Named Patient & Paid-For Programs: Ethical & Practical Considerations
Time: 2:45 pm
day: Conference Day Two
Details:
- Exploring the reasons for switching to a named-patient program, including the potential benefits of generating revenue through such models
- Delving into the ethical implications and governance processes required when transitioning from compassionate use to paid-for programs
- Learning strategies to address the challenges that arise when a drug is approved in one country but patients in other regions seek access through paid programs
